SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is seeing significant bullish momentum as it nears record highs, fueled by intense investor interest in the ongoing AI infrastructure build-out and sustained institutional demand. The community is actively debating the stock's valuation and long-term trajectory, with many focusing on its critical role as the primary enabler of the AI revolution despite broader market volatility and geopolitical concerns.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is facing a massive sell-off after Marvell cancelled all purchase orders citing an NDA breach, fueling intense community debate over management's professional conduct and the future viability of their technology. Investors are actively questioning the company's credibility and long-term path forward, with discussions centered on potential legal fallout, executive accountability, and whether this represents a total loss of trust or a speculative buying opportunity.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors digest the strategic consolidation of its Tanbreez rare earth asset and the potential impact of a significant share-canceling acquisition of European Lithium. The community is actively debating the stock's role in securing Western defense supply chains and closely monitoring institutional activity and borrowing costs as indicators of a potential short squeeze.

High-Trend International Group is a holding company. It engages in shipping decarbonization and carbon asset management platforms. The company was founded in 2021 and is headquartered in Singapore.

High-Trend International Group. - Ordinary Shares - Class A

HTCO is seeing significant retail interest driven by its status as a high-volatility, low-float stock capable of rapid price movements. Community sentiment remains highly polarized, with active discussions focused on the potential for short squeezes, recent corporate governance updates, and skepticism surrounding the stock's long-term sustainability.

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquisition, development, and commercialization of drug candidates for medical dermatology and respiratory diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.

Edesa Biotech Inc

Edesa Biotech is experiencing a surge driven by significant institutional accumulation, aggressive insider buying, and positive clinical momentum surrounding its paridiprubart trial results. Community members are actively speculating about potential buyout scenarios and near-term regulatory catalysts, while debating the impact of the stock's low effective float on its recent volatile price action.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending following a significant rally driven by a new multibillion-dollar share buyback authorization and a dividend increase, which have boosted investor sentiment. The community is actively debating the stock's long-term potential in AI and edge computing versus concerns about handset market headwinds and competitive pressures.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently a focal point for investors as the community debates the significance of its Phase 3 HAE data against the backdrop of significant short interest. Discussions are split between those anticipating a major squeeze driven by fundamental validation of its gene-editing platform and skeptics wary of commercialization hurdles, dilution risks from the company's ATM program, and strong competition in the sector.

McDonald's Corp. engages in the operation and franchising of restaurants. It operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. The firm's products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, McCafe beverages, and other beverages. The company was founded by Raymond Albert Kroc on April 15, 1955, and is headquartered in Oak Brook, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is trending as investors digest a solid quarterly earnings beat, with strong sales growth driven by aggressive value strategies and loyalty program engagement. The stock has seen heightened activity and volatility as traders weigh the chain's ability to maintain resilient performance amid persistent inflation and shifting consumer dining habits.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently experiencing significant market volatility driven by the registration of millions of shares tied to CEO Elon Musk's compensation package and ongoing debates regarding the company's autonomous driving strategy. Investors remain sharply divided, with bulls pointing to long-term AI and robotics potential, while bears focus on margin pressures and a narrative they argue has detached from current delivery and growth fundamentals.

Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.

Sagimet Biosciences Inc - Ordinary Shares - Series A

Sagimet Biosciences Inc

Sagimet Biosciences is trending following a 175 million dollar underwritten offering aimed at funding its Phase 3 acne trial and advancing its pipeline, driving significant debate among investors about the dilution impact versus the potential for long-term growth. While the stock has seen high volume and sharp price swings, the community remains divided, with some traders targeting technical breakout levels while long-term investors highlight the asset's de-risking as a potential catalyst for future partnerships or acquisition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Joby Completes First-Ever NYC Air Taxi Flight

Joby Aviation completes NYC's first point-to-point electric air taxi flights, showcasing the future of quiet, emission-free urban travel.read more...

Archer and eVTOL Pilot Programs: Why 2026 Could Be Pivotal

ACHR eyes 2026 as a credibility test year, with pilot programs, demos, and certification progress key to shifting its story beyond early-stage uncertainty.

Archer Stock Valuation: Multiples vs Cash Burn and Liquidity

ACHR's lofty valuation faces pressure as heavy cash burn, rising losses and certification risks test investor patience despite a $2B liquidity cushion.

ACHR Stock: What Midnight's 2026 Certification Steps Signal

Archer's 2026 FAA certification steps for Midnight sharpen its path to market, but timing risks and rising spend could shape its next phase.

Traders Buy Large Volume of Joby Aviation Call Options (NYSE:JOBY)

Joby Aviation, Inc. (NYSE:JOBY - Get Free Report) saw some unusual options trading on Monday. Stock traders acquired 39,798 call options on the company. This is an increase of 40% compared to the...

Joby Brings Electric Air Taxis to New York City in Week-Long Flight Campaign

Joby Aviation, Inc. (NYSE:JOBY), a company developing electric air taxis for commercial passenger service, today announced the completion of the first-ever point-to-point electric vertical takeoff...

Airline Stocks To Watch Now - April 25th

United Airlines, American Airlines Group, Delta Air Lines, Southwest Airlines, and Joby Aviation are the five Airline stocks to watch today, according to MarketBeat's stock screener tool. Airline stocks are shares of publicly traded companies whose primary business is operating passenger and cargo...

Down Nearly 60% From Its Peak, Is It Finally Time to Buy Joby Aviation?

Key PointsJoby's stock has plummeted from its all-time high...

Uber and Joby Aviation Confirm Air Taxis Launch in Dubai by 2026 -- Time to Buy?

Key PointsJoby Aviation and Uber are moving forward with the launch of eVTOL taxi services this year...

Best Airline Stocks Worth Watching - April 24th

United Airlines, American Airlines Group, Delta Air Lines, Southwest Airlines, and Joby Aviation are the five Airline stocks to watch today, according to MarketBeat's stock screener tool. Airline...

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Earnings

Fed / Macro data

Headlines / Geopolitics

Other (drop a comment)

What will be the main driver of the market this week?

Stocktwits

Stocktwits Polls

Investors are buzzing about the high-profile New York City demonstration flights designed to showcase eVTOL viability in urban environments.

Traders are intensely debating the future of the air taxi race by comparing key market players, their technical milestones, and valuation metrics.

While frustrated by price volatility, some investors see the $8.50 area as a pivotal accumulation zone for long-term gains.

JOBY
Joby Aviation Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest JOBY News

JOBYJoby Aviation Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest JOBY News

JOBY
Joby Aviation Inc